QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Exciting news for those looking to enhance their Market Access and Real World Evidence (RWE) efforts in Finland!
Our capabilities have significantly expanded, allowing us to offer comprehensive support for your Finnish data and access needs.
As the leading provider of Nordic RWE and market access services, we’ve strengthened our Finnish presence to deliver:
▪ End-to-end RWE including patient-level data access, biobanks, Findata permits, statistical analyses, reporting, manuscripts, and other medical communications
▪ Economic modelling, reimbursement dossiers, and strategic support to ensure your product reaches patients in need, through PPB […]
Nordic data – Why all the hype?
The Nordic region (often called Scandinavia) is home to some of the world’s best real-world data (RWD), driving the development of pharmaceuticals and medical devices. As high-quality RWD becomes increasingly important to regulators and payers, it is critical for real-world evidence (RWE) practitioners across the globe to develop a working knowledge of the region’s data characteristics and ecosystem in order to interpret and deploy Nordic RWD.
As summer is drawing to a close up here in the northern hemisphere, many of our clients are back from vacations and it´s time to sharpen our pencils and open our diaries
We have an exciting and action-packed fall ahead of us, including:
– Growing our global service offering (including our newest office in Finland!)
– Annual September Kick-off
– Leadership training for senior staff
– A number of conferences, such as ISPOR EU, DIA RWE and AI in RWE (see you there!)
– Continuing our projects across many different disease areas
If you (like us) are busy making plans for the coming months, we would be […]
Proud team moment!
Last week a whooping 3 teams of Quantify Research colleagues took part in the annual Convini relay race in Stora Skuggan in Stockholm – our biggest turnout yet!
A relay race truly embodies what we at Quantify are all about as you can’t complete a relay without a strong team that works well together.
Well done to everyone who took part!
[…]